Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
+$1.14B |
| 2 |
AbbVie
ABBV
|
+$537M |
| 3 |
T-Mobile US
TMUS
|
+$504M |
| 4 |
Baidu
BIDU
|
+$474M |
| 5 |
Kroger
KR
|
+$448M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.32B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$504M |
| 5 |
Humana
HUM
|
+$466M |
Sector Composition
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.11% |
| 3 | Consumer Staples | 10.59% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Abeona Therapeutics
ABEO
$342M
| $535K | ﹤0.01% |
7,341
+4,332
| +144% | +$316K |
|
2852
VYNE Therapeutics
VYNE
$8.09M
| $535K | ﹤0.01% |
+4,295
| New | +$535K |
|
2853
MGIC Investment
MTG
$6.63B
| $533K | ﹤0.01% |
65,100
-3,597,367
| -98% | -$29.5M |
|
|
ZEN
2854
DELISTED
ZENDESK INC
ZEN
| $531K | ﹤0.01% |
6,000
-22,100
| -79% | -$1.96M |
|
2855
Invesco CurrencyShares Japanese Yen Trust
FXY
$561M
| $526K | ﹤0.01% |
+6,000
| New | +$526K |
|
|
VYNT
2856
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $526K | ﹤0.01% |
34,700
+2,512
| +8% | +$38.1K |
|
|
TCRR
2857
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $524K | ﹤0.01% |
34,100
-17,200
| -34% | -$264K |
|
2858
Genesco
GCO
$351M
| $522K | ﹤0.01% |
24,100
-151,600
| -86% | -$3.28M |
|
2859
Schwab US Dividend Equity ETF
SCHD
$72B
| $518K | ﹤0.01% |
30,000
-27,000
| -47% | -$466K |
|
2860
Good Times Restaurants
GTIM
$17.5M
| $516K | ﹤0.01% |
419,240
+74,016
| +21% | +$91.1K |
|
2861
Organogenesis Holdings
ORGO
$629M
| $516K | ﹤0.01% |
134,500
+66,900
| +99% | +$257K |
|
2862
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.26B
| $515K | ﹤0.01% |
+9,200
| New | +$515K |
|
2863
Hyatt Hotels
H
$13.8B
| $513K | ﹤0.01% |
+10,200
| New | +$513K |
|
2864
MGP Ingredients
MGPI
$594M
| $513K | ﹤0.01% |
13,973
-52,600
| -79% | -$1.93M |
|
2865
Scansource
SCSC
$990M
| $513K | ﹤0.01% |
+21,310
| New | +$513K |
|
2866
Unity Bancorp
UNTY
$524M
| $513K | ﹤0.01% |
35,901
-19,000
| -35% | -$271K |
|
2867
Shoe Carnival
SCVL
$634M
| $512K | ﹤0.01% |
35,000
-19,800
| -36% | -$290K |
|
2868
Invesco S&P 500 High Beta ETF
SPHB
$449M
| $512K | ﹤0.01% |
+12,800
| New | +$512K |
|
|
XIN
2869
DELISTED
Xinyuan Real Estate
XIN
| $512K | ﹤0.01% |
23,380
-3,440
| -13% | -$75.3K |
|
2870
Inuvo
INUV
$52M
| $511K | ﹤0.01% |
95,629
-70,708
| -43% | -$378K |
|
2871
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$710M
| $508K | ﹤0.01% |
+16,741
| New | +$508K |
|
2872
INNOVATE Corp
VATE
$67.6M
| $508K | ﹤0.01% |
15,210
-13,026
| -46% | -$435K |
|
2873
RCI Hospitality Holdings
RICK
$301M
| $503K | ﹤0.01% |
36,300
-218,450
| -86% | -$3.03M |
|
2874
Cyclerion Therapeutics
CYCN
$8.17M
| $502K | ﹤0.01% |
4,250
+1,460
| +52% | +$172K |
|
2875
US Global Investors
GROW
$31.9M
| $500K | ﹤0.01% |
263,016
+144,690
| +122% | +$275K |
|